|
|
|
Stebnev S.D., Stebnev V.S., Malov V.M. CHROMOVITRECTOMY OF SYMPTOMATIC VITREO-MACULAR ADHESIONCOMPLICATED BY EARLY STAGES OF PRIMARY FULL-THICKNESS MACULAR HOLESChromovitrectomy — modern section of vitreoretinal surgery involving the use during surgery endovitreal dyes for better visualization of the vitreous, preretinal and retinal structures. This technology involves the selective recruitment endovitreal dyes for staining structures of the posterior segment of the eye, which creates a useful contrast edges of the removed structures, extends the identification of the true boundaries of the pathological membranes, improves the visualization of the underlying internal limiting membrane, allows you to operate on patients at earlier stages of the disease, and with less injuries. Central pathogenetic role in the development of primary full-thickness macular hole is traction symptomatic effects of vitreo-macular adhesion (sVMA) on foveolar region. Studied the clinical efficacy of chromovitrectomy in the surgery of symptomatic vitreo-macular adhesion, complicated by primary full-thickness macular hole in the early stages of its formation in 42 patients. The patients age from 46 to 72 years (average of 64.5 m± 3.2 m). Women — 31 (74 %), men — 11 (26 %). In 23 patients primary full-thickness macular hole was classified as stage I, 19 — II stage. Using technology chromovitrectomy may guaranteed eliminate symptomatic of vitreo-macular adhesion. All 42 patients with this disease who were under surveillance, was able to eliminate symptomatic of vitreo-macular adhesion and to achieve primary closure of full thickness macular holes. The use of technology chromovitrectomy symptomatic of vitreo-macular adhesion, complicated by primary full-thickness macular hole, allows to obtain a high anatomical and functional results that provides a basis to apply active surgical tactics in the early stages of primary full-thickness macular hole.Key words: chromovitrectomy, symptomatic vitreo-macular adhesion, primary full-thickness macular hole.
References:
1. Стебнев С.Д., Стебнев В.С., Сытник Е.А. хромовитрэктомия с "BrilliantBlueG" при выполнении макулорексиса. // Вестник оренбургского государственного университета. — 2009. — №12 — С.135-138.
2. Кислицына Н.М., Новиков С.В., Беликова С.В. Хромовитрэктомия // Практическая медицина. — 2010. — № 4 (59). — С. 85-89.
3. Шкворченко Д.О., Каштан О.В., Осокин И.Г., Русановская А.В., Белоусова Е.В. Поэтапная хромовитрэктомия при осложненной форме пролиферативной диабетической ретинопатии. // В кн.: Современные технологии лечения витреоретинальной патологии — 2013. — М., 2013. — С.209-211.
4. Meyer C. Vital dyes in vitreoretinal surgery — chromovitrectomy. // Developments in Ophthalmology. Karger. — 2008.
5. Бойко Э.В. Суетов А.А. Мальцев Д.С. Отслойка задней гиалоидной мембраны: понятие, распространенность, классификация, клиника и возможные причины. // Офтальмологические ведомости 2009г. Том 2 № 3 С. 39-46.
6. StalmansP, BenzMS, GandorferA et al (2012) Enzymatic vitreolysis with ocriplasmin for vitreomacular traction and macular holes. NEnglJ Med 367:606–615.
7. Sebag J. Vitreous in Health and Disease. NewYork. 2014. P.925
8. Gass J. Stereoscopic Atlas of Macular Diseases: Diagnosis and Treatment, ed3. St Louis, Mosby. — 1987. — P. 564.
9. HeeMR, PuliafitoCA, WongC, DukerJS, ReichelE, SchumanJS, SwansonEA, FujimotoJG (1995) Optical coherence tomography of macular holes. Ophthalmology 102(5):748–756
10. Gaudric A, Haouchine B, Massin Petal (1999) Macular hole formation: new data provided by optical coherence tomography. Arch Ophthalmol 117:744–751
11. Eckardt C., Eckardt U., Groos S, Luciano L., Reale E. //Removal of the internal limiting membrane in macular holes: clinical and morphological findings. // Ophthalmologe. –1997. — Vol. 94. — P. 545-551.
12. GuptaP, YeeKMP, GarciaP, RosenRB, ParikhJ, HagemanGS, SadunAA, SebagJ (2011) Vitreoschisis in macular diseases. Br J Ophthalmol 95(3):376–380
13. SchumannR, SchaumbergerM, RohlederM. (2006) Ultrastructure of the vitromacular interface in full thickness idiopathic macular holes: a consecutive analysis of 100 cases. // Am J Ophthalmol 141:1112–1119
14. Haritoglou C, Schumann RG, Kampik A &Gandorfer A (2011): Heavy brilliant blue G for internal limiting membrane staining. Retina 31: 405–407.
15. Farah M.E., Maia M., Rodrigues E.B. Dyes in ocular surgery: principles for use in chromovitrectomy. Am J Ophthalmol. 2009;148(3):332–340.
About this article
Authors: Stebnev S.D., Stebnev V.S., Malov V.M.
Year: 2015
|
|
Editor-in-chief |
Sergey Aleksandrovich MIROSHNIKOV |
|
|